| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |